{"gene":"TNIP1","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":2006,"finding":"ABIN-1 (TNIP1) physically binds NEMO/IKKγ and facilitates A20-mediated de-ubiquitination of NEMO/IKKγ, thereby inhibiting NF-κB activation. ABIN-1 links A20 to NEMO/IKKγ; siRNA targeting ABIN-1 abrogates A20-dependent de-ubiquitination of NEMO/IKKγ.","method":"Co-immunoprecipitation, siRNA knockdown, NF-κB reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and functional siRNA experiments in single lab with multiple orthogonal methods","pmids":["16684768"],"is_preprint":false},{"year":2003,"finding":"ABIN-1 contains an ABIN homology domain (AHD) shared with IKKγ/NEMO; site-specific mutagenesis of this AHD2 region abolishes NF-κB inhibitory function without affecting A20 interaction, indicating A20 binding and NF-κB inhibition are separable activities. Dominant-negative AHD2 mutants interfere with ABIN-1 but not A20-mediated NF-κB inhibition.","method":"Site-directed mutagenesis, NF-κB reporter assays, co-immunoprecipitation","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — mutagenesis with functional validation plus protein interaction assays in single lab","pmids":["12586352"],"is_preprint":false},{"year":2008,"finding":"ABIN-1 directly binds polyubiquitin chains (ubiquitin-sensing activity), and this activity is required for its anti-apoptotic function. ABIN-1-deficient mice die embryonically with fetal liver apoptosis rescued by TNF deficiency; ABIN-1 inhibits caspase-8 recruitment to FADD in TNF-induced signaling complexes, preventing caspase-8 cleavage and programmed cell death.","method":"Knockout mouse model, genetic rescue (TNF deficiency), biochemical ubiquitin-binding assays, signaling complex analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo knockout with genetic epistasis, direct biochemical ubiquitin-binding assay, and mechanistic complex analysis in single rigorous study","pmids":["19060883"],"is_preprint":false},{"year":2017,"finding":"ABIN-1 is recruited to the TNF-RSC in a LUBAC-dependent (Met1-ubiquitin-dependent) manner and regulates A20 recruitment to control Lys63 deubiquitylation of RIPK1. ABIN-1 deficiency reduces A20 recruitment, promotes Lys63 ubiquitylation and activation of RIPK1, and licenses necroptosis. RIPK1 kinase inhibition and RIPK3 deficiency rescue embryonic lethality of Abin-1−/− mice.","method":"Knockout mouse model, genetic rescue experiments, biochemical analysis of TNF-RSC complex, ubiquitylation assays, RIPK1 kinase inhibitor treatment","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods including in vivo genetic rescue, complex biochemistry, and pharmacological inhibition in one rigorous study","pmids":["29203883"],"is_preprint":false},{"year":2009,"finding":"ABIN-1 inhibits NF-κB by blocking processing of the p105 precursor to the p50 active subunit. ABIN-1 physically interacts with p105, and this interaction stabilizes ABIN-1 and increases its inhibitory effect. The AHD2 domain of ABIN-1 is required for inhibition of p105 processing.","method":"Co-immunoprecipitation, NF-κB reporter assays, domain deletion analysis, Western blotting","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP with domain mapping and functional assays in single lab","pmids":["19695220"],"is_preprint":false},{"year":2005,"finding":"Adenoviral ABIN-1 expression protects mice from TNF/galactosamine-induced acute liver failure; ABIN-1 prevents both TNF-induced NF-κB activation and hepatocyte apoptosis, demonstrating an NF-κB-independent anti-apoptotic activity distinct from IκBα superrepressor.","method":"Adenoviral gene transfer in murine liver failure model, comparison with IκBα superrepressor, histological analysis of apoptosis and inflammation","journal":"Hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gene transfer with mechanistic comparison to IκBα, single lab","pmids":["16025521"],"is_preprint":false},{"year":2013,"finding":"ABIN-1 deficiency specifically in dendritic cells leads to exaggerated NF-κB and MAPK signaling and increased IL-23 production in response to TLR ligands. DC-specific ABIN-1 deletion causes psoriasiform lesions upon TLR7 challenge, and these phenotypes are reversed by DC-specific deletion of the TLR adaptor MyD88, placing ABIN-1 upstream of MyD88 in DC TLR signaling.","method":"Conditional knockout mice (CD11c-Cre), MyD88 genetic epistasis, cytokine measurements, flow cytometry for Th17/TCRγδ T cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type specific conditional KO with genetic epistasis (MyD88 rescue) clearly placing ABIN-1 upstream of MyD88 in TLR signaling in DCs","pmids":["23785118"],"is_preprint":false},{"year":2016,"finding":"Loss of Tnip1 in keratinocytes leads to deregulated IL-17-induced gene expression and exaggerated chemokine production in vitro and overt psoriasis-like inflammation in vivo; tissue-specific deletion established that keratinocytes are a cell-autonomous contributor to psoriasis pathogenesis through TNIP1.","method":"Tissue-specific conditional knockout mice, in vitro keratinocyte stimulation with IL-17, in vivo inflammatory triggers","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with defined molecular phenotype (IL-17 signaling) and in vitro/in vivo orthogonal confirmation","pmids":["27671649"],"is_preprint":false},{"year":2018,"finding":"A20 and ABIN-1 synergistically restrict TNF-induced caspase-8 activation and RIPK1 kinase activity in intestinal epithelial cells. Simultaneous IEC-specific deletion of both A20 and ABIN-1 causes spontaneous cell death and mouse lethality; single deletion of either alone has negligible effect. Inhibition of RIPK1 kinase alone, or caspase inhibition plus RIPK3 deletion, rescues the double-deficient phenotype.","method":"Conditional double-knockout mice, enteroid culture, genetic rescue experiments (RIPK1 inhibitor, RIPK3 deletion, caspase inhibition), caspase-8 activation assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional double-KO with multiple genetic epistasis rescues, cell-autonomous enteroid confirmation, single rigorous study","pmids":["29930103"],"is_preprint":false},{"year":2022,"finding":"TBK1 phosphorylates TNIP1 under inflammatory conditions (TLR3/poly(I:C) stimulation), activating its LIR motif and leading to selective autophagy-dependent degradation of TNIP1. This early (0–4 h) degradation allows efficient initiation of the inflammatory response, after which TNIP1 levels are restored by increased transcription to prevent sustained inflammation.","method":"Phosphoproteomics, TBK1 inhibitor treatment, autophagy flux assays, LIR motif mutagenesis, quantitative proteomics","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — identification of kinase (TBK1), phosphorylation-dependent LIR activation, and autophagy-dependent degradation with mutagenesis and multiple orthogonal methods","pmids":["36574265"],"is_preprint":false},{"year":2023,"finding":"TNIP1 negatively regulates mitophagy via a bipartite interaction: an evolutionarily conserved LIR motif binds LC3/GABARAP family proteins, and an AHD3 domain binds autophagy receptor TAX1BP1. TNIP1 knockout accelerates mitophagy; phosphorylation of TNIP1 regulates its association with the ULK1 complex member FIP200, allowing TNIP1 to compete with autophagy receptors at early steps of autophagosome biogenesis.","method":"TNIP1 knockout HeLa cells, ectopic overexpression, LIR/AHD3 domain mutagenesis, Co-IP with LC3/GABARAP/TAX1BP1/FIP200, mitophagy flux assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — domain mutagenesis, protein interaction validation, KO and OE rescue experiments, multiple orthogonal methods in single rigorous study","pmids":["36898370"],"is_preprint":false},{"year":2022,"finding":"ABIN-1 is recruited to the CBM (CARD11-BCL10-MALT1) signalosome in activated T cells; its suppressive function in T cells depends on A20. A20 suppresses CBM complex-triggered NF-κB and MALT1 protease activity independent of ABIN-1, but ABIN-1's suppressive function requires A20. A20/ABIN-1 is recruited via A20 ZnF4/7; proteasomal degradation of both releases the CBM from negative regulation. ABIN-1 also antagonizes MALT1-catalyzed cleavage of re-synthesized A20.","method":"Quantitative mass spectrometry interactome, T cell activation assays, NF-κB reporter, MALT1 protease assay, overexpression and knockdown experiments","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative MS-based interactome plus functional assays, single lab","pmids":["35099607"],"is_preprint":false},{"year":2018,"finding":"ABIN-1 heterozygosity sensitizes cells to antiviral response by mediating NF-κB-dependent, RIPK1-independent upregulation of pattern recognition molecules TLR3, RIG-I, and MDA5. Prolonged poly(I:C) stimulation leads to A20-dependent reduction of ABIN-1 protein. RIPK1 kinase inhibition partially reduces pattern recognition molecule expression in Abin-1+/- but not WT mice.","method":"Heterozygous Abin-1+/- mouse model, in vivo cytokine measurements, MEF signaling studies, RIPK1 kinase inhibitor treatment","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo mouse model plus pharmacological inhibition, single lab","pmids":["30341420"],"is_preprint":false},{"year":2017,"finding":"IL-17 signaling induces proteasome-dependent degradation of ABIN-1 protein, while simultaneously inducing ABIN-1 mRNA through NF-κB. ABIN-1 restricts both baseline and IL-17-induced NF-κB signaling independently of A20 in IL-17-responsive fibroblasts.","method":"Protein stability assays, proteasome inhibitor treatment, NF-κB reporter assays, siRNA knockdown of A20, promoter activity assays","journal":"ImmunoHorizons","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — proteasome inhibitor-based mechanism plus multiple cell-based assays, single lab","pmids":["30761389"],"is_preprint":false},{"year":2009,"finding":"TNIP1 interacts with liganded RARα and RARγ via NR boxes (LXXLL motifs) in a ligand- and receptor AF-2 domain-dependent manner characteristic of coactivators, yet TNIP1 represses RAR transcriptional activity. Repression is partially relieved by SRC1 coactivator, suggesting TNIP1 competes with coactivators. RARα preference over RARγ maps to helices 5-9 of the RARα ligand-binding domain.","method":"Two-hybrid assays, co-immunoprecipitation, RAR transcriptional activity reporter assays, domain deletion mapping","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — multiple protein interaction and functional assays with domain mapping, single lab","pmids":["19732752"],"is_preprint":false},{"year":2011,"finding":"TNIP1 is an atypical corepressor of agonist-bound PPARα (and other PPARs); identified from a PPARα screen of a human keratinocyte cDNA library. TNIP1-PPAR interaction requires ligand and the receptor AF-2 domain. TNIP1 has separable transcriptional activation and repression domains. TNIP1 partially decreases PPAR transcriptional activity.","method":"cDNA library two-hybrid screen, co-immunoprecipitation, PPAR transcriptional reporter assays, domain deletion analysis","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — library screen plus functional validation with domain analysis, single lab","pmids":["21967852"],"is_preprint":false},{"year":2011,"finding":"TNIP1 localizes to both cytoplasm and nucleus in normal human skin keratinocytes, where it co-localizes with RARα. Nuclear and cytoplasmic distribution is also observed in malignant keratinocytes of squamous cell carcinomas, with varying levels in different tumor types.","method":"Immunohistochemistry, co-localization analysis in tissue sections and cultured cells","journal":"The journal of histochemistry and cytochemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization with co-localization to known binding partner RARα, multiple tissue types but without direct functional consequence assay","pmids":["22147607"],"is_preprint":false},{"year":2011,"finding":"PPARγ and NF-κB directly regulate the TNIP1 gene promoter; validated NF-κB binding sites in proximal and distal promoter regions and one PPRE in the distal region were confirmed by EMSA and ChIP assays, establishing a feedback loop where NF-κB and PPARγ control their own inhibitor.","method":"Luciferase reporter assays, EMSA, chromatin immunoprecipitation (ChIP), expression studies","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — ChIP and EMSA with functional reporter validation, single lab, multiple orthogonal methods","pmids":["22001530"],"is_preprint":false},{"year":2012,"finding":"TNIP1 promoter is activated by retinoic acid (ATRA) via RAR-responsive elements (RAREs) in proximal and distal promoter regions, confirmed by EMSA, ChIP, and luciferase assays. This establishes a feedback loop: RARs activate TNIP1 expression, and TNIP1 in turn attenuates RAR activity.","method":"Luciferase reporter assays, EMSA, ChIP, expression studies with ATRA treatment","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — ChIP and EMSA with functional reporter confirmation, single lab, multiple orthogonal methods","pmids":["23228856"],"is_preprint":false},{"year":2018,"finding":"NLRP10 binds ABIN-1 through its NACHT domain and destabilizes ABIN-1, resulting in enhanced proinflammatory NF-κB signaling during Shigella flexneri infection in human epithelial cells.","method":"Co-immunoprecipitation (NLRP10-ABIN-1), domain mapping, protein stability assays, NF-κB signaling readouts in infected cells","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP with domain mapping and functional signaling readout, single lab","pmids":["30510071"],"is_preprint":false},{"year":2022,"finding":"ABIN-1 directly binds LC3A and LC3B via LIR motifs (LIR1 and LIR2); mutations in both LIR motifs abolish ABIN-1/LC3B-II complex formation. ABIN-1 translocates to damaged mitochondria and promotes mitophagy; CRISPR/Cas9 deletion of ABIN-1 inhibits degradation of outer mitochondrial membrane proteins VDAC-1, MFN2, and TOM20.","method":"Bacterial protein expression and direct binding assays, LIR motif mutagenesis, colocalization (fluorescence microscopy), CRISPR knockout, siRNA knockdown, mitophagy flux reporters","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct in vitro binding with mutagenesis, CRISPR KO phenotype, and live-cell mitophagy reporters; multiple orthogonal methods in single study","pmids":["36440857"],"is_preprint":false},{"year":2017,"finding":"ABIN-1 physically associates with the μ-opioid receptor (MOR) C-terminal tail, confirmed by bacterial two-hybrid screen and co-immunoprecipitation. ABIN-1 inhibits DAMGO-induced G protein activation, MOR phosphorylation, ubiquitination, internalization, and ERK activation in CHO cells. ABIN-1 morpholino knockdown in zebrafish increases morphine-induced hyperlocomotion.","method":"Bacterial two-hybrid screen, co-immunoprecipitation, G protein activation assay (GTPγS), radioligand binding, adenylyl cyclase assay, zebrafish morpholino knockdown","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, multiple functional receptor assays, and in vivo zebrafish validation; single lab","pmids":["29237725"],"is_preprint":false},{"year":2023,"finding":"FTO (m6A demethylase) erases m6A methylation on TNIP1 mRNA, repressing TNIP1 expression. FTO-mediated reduction of TNIP1 activates NF-κB and inflammatory factors in endothelial cells. Confirmed by MeRIP-seq, RNA-seq, luciferase activity assays, and RNA pull-down; intravitreal AAV-Tnip1 delivery alleviates diabetic retinal vascular damage.","method":"MeRIP-sequencing, RNA-seq, luciferase activity assays, RNA pull-down, FTO knockdown, AAV-mediated TNIP1 overexpression in vivo","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — MeRIP-seq identifies m6A site, RNA pull-down and luciferase confirm FTO-TNIP1 regulatory axis, in vivo rescue confirms functional consequence; multiple orthogonal methods","pmids":["37781923"],"is_preprint":false},{"year":2024,"finding":"A TNIP1 Q333P variant impairs TNIP1 localization to damaged mitochondria and mitophagosome formation, and impairs MyD88 and IRAK1 recruitment to autophagosomes, resulting in increased interferon-β and TLR7-driven autoimmunity. B cell autoimmune phenotypes from this variant are cell-autonomous and rescued by ablation of TLR7 or MyD88.","method":"Whole-exome sequencing, knock-in mouse model (Q346P), cell-autonomous B cell transfer experiments, TLR7/MyD88 knockout epistasis, mitochondrial localization imaging, autophagosome recruitment assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — knock-in mouse with genetic epistasis (TLR7/MyD88 rescue), cell-autonomous transfer, and direct mechanistic subcellular localization studies in one rigorous study","pmids":["39060650"],"is_preprint":false},{"year":2016,"finding":"LILRB1 ligation during monocyte-to-DC differentiation increases ABIN1/TNIP1 expression, mediating inhibitory effects on DC function. siRNA-mediated reduction of ABIN1/TNIP1 in these cells allows NF-κB nuclear translocation, increased surface antigen presentation molecules, phagocytic capacity, proinflammatory cytokine secretion, and T cell stimulation.","method":"siRNA knockdown of TNIP1 in DCs/monocytes, NF-κB translocation assay, flow cytometry for surface markers, phagocytosis assay, cytokine ELISA, T cell co-culture","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — siRNA KD with multiple downstream functional readouts, single lab","pmids":["27129285"],"is_preprint":false}],"current_model":"TNIP1 (ABIN-1) is a multifunctional ubiquitin-sensing scaffold protein that inhibits NF-κB by binding polyubiquitin chains, linking A20 to NEMO/IKKγ for de-ubiquitylation, blocking p105 processing, and competing with autophagy receptors for FIP200/ULK1 complex access; it restricts TNF-induced apoptosis and necroptosis by preventing caspase-8/FADD complex assembly and RIPK1 Lys63-ubiquitylation/activation, acts as a corepressor of agonist-bound nuclear receptors (RARs, PPARs), undergoes TBK1-phosphorylation-dependent LIR-mediated autophagic degradation to permit inflammatory initiation, and is recruited to damaged mitochondria to promote mitophagy, with a disease-associated Q333P variant impairing mitophagosome formation and MyD88/IRAK1 autophagosomal recruitment, thereby amplifying TLR7-driven autoimmunity."},"narrative":{"mechanistic_narrative":"TNIP1 (ABIN-1) is a ubiquitin-sensing scaffold protein that restrains inflammatory and cell-death signaling and, through a distinct set of domains, modulates selective autophagy [PMID:19060883, PMID:29203883, PMID:36898370]. As an NF-κB inhibitor it binds polyubiquitin chains and uses an ABIN homology domain (AHD2) genetically separable from its A20-binding activity to block NF-κB; it links A20 to NEMO/IKKγ to drive NEMO de-ubiquitination and additionally blocks processing of the p105 precursor to p50 [PMID:16684768, PMID:12586352, PMID:19695220]. At the TNF receptor signaling complex it is recruited in a LUBAC/Met1-ubiquitin-dependent manner where it controls A20 recruitment and limits Lys63 ubiquitylation and activation of RIPK1, thereby preventing caspase-8/FADD-dependent apoptosis and licensing of necroptosis; loss of TNIP1 causes TNF-dependent embryonic lethality rescuable by TNF deficiency or RIPK1/RIPK3 inactivation [PMID:19060883, PMID:29203883, PMID:29930103]. This cell-death-restraining role is partly synergistic with A20 in intestinal epithelium [PMID:29930103]. In innate and adaptive immunity TNIP1 acts upstream of MyD88 in dendritic-cell TLR signaling and restrains IL-17-induced NF-κB programs in keratinocytes, with cell-type-specific loss producing psoriasis-like inflammation [PMID:23785118, PMID:27671649]. TNIP1 is itself a node of feedback control: its expression is induced by NF-κB, PPARγ, and retinoic-acid receptors through defined promoter elements, and it acts as an atypical corepressor of agonist-bound RARs and PPARs via LXXLL/NR-box motifs [PMID:19732752, PMID:21967852, PMID:22001530, PMID:23228856]. Beyond signaling, TNIP1 uses a conserved LIR motif that binds LC3/GABARAP and an AHD3 domain that binds TAX1BP1, and its phosphorylation-regulated association with FIP200 lets it compete with autophagy receptors to negatively regulate mitophagy; TBK1-driven, LIR-dependent autophagic degradation of TNIP1 permits initiation of inflammation [PMID:36574265, PMID:36898370, PMID:36440857]. A disease-associated Q333P variant impairs TNIP1 recruitment to damaged mitochondria and MyD88/IRAK1 autophagosomal recruitment, amplifying TLR7-driven autoimmunity [PMID:39060650].","teleology":[{"year":2003,"claim":"Established that TNIP1's NF-κB-inhibitory activity is structurally and functionally separable from its A20 interaction, defining the AHD2 domain as the effector module.","evidence":"Site-directed mutagenesis of the AHD2 region with NF-κB reporter and Co-IP assays","pmids":["12586352"],"confidence":"Medium","gaps":["Molecular target through which AHD2 blocks NF-κB not defined","Single-lab functional mutagenesis"]},{"year":2006,"claim":"Showed how TNIP1 inhibits NF-κB mechanistically: it bridges A20 to NEMO/IKKγ to enable A20-dependent de-ubiquitination.","evidence":"Co-IP, siRNA knockdown, and NF-κB reporter assays","pmids":["16684768"],"confidence":"Medium","gaps":["Stoichiometry of the A20-TNIP1-NEMO complex not resolved","In vivo relevance not tested here"]},{"year":2009,"claim":"Extended the NF-κB-inhibitory repertoire by showing TNIP1 blocks p105-to-p50 processing through a p105 interaction requiring AHD2.","evidence":"Co-IP, domain deletion, and NF-κB reporter assays","pmids":["19695220"],"confidence":"Medium","gaps":["Mechanism of processing inhibition unresolved","Single-lab overexpression-based"]},{"year":2005,"claim":"Demonstrated an NF-κB-independent anti-apoptotic function in vivo distinct from IkBa, separating TNIP1's death-protective and transcriptional roles.","evidence":"Adenoviral TNIP1 transfer in a murine TNF/galactosamine liver-failure model with IkBa comparison","pmids":["16025521"],"confidence":"Medium","gaps":["Molecular basis of the anti-apoptotic activity not defined at this stage"]},{"year":2008,"claim":"Defined TNIP1 as a polyubiquitin-binding protein essential for survival, linking ubiquitin sensing to suppression of caspase-8/FADD-driven apoptosis.","evidence":"Knockout mice with TNF-deficiency genetic rescue, biochemical ubiquitin-binding assays, and TNF signaling complex analysis","pmids":["19060883"],"confidence":"High","gaps":["Ubiquitin chain-type specificity only partly defined","Did not address necroptosis arm"]},{"year":2017,"claim":"Resolved how TNIP1 restrains necroptosis: LUBAC/Met1-ubiquitin-dependent recruitment to the TNF-RSC positions it to control A20 recruitment and RIPK1 Lys63-ubiquitylation/activation.","evidence":"Knockout mice, TNF-RSC biochemistry, ubiquitylation assays, and RIPK1-kinase-inhibitor/RIPK3-deficiency rescue of lethality","pmids":["29203883"],"confidence":"High","gaps":["Direct Met1-ubiquitin binding by TNIP1 vs indirect recruitment not fully separated"]},{"year":2018,"claim":"Showed A20 and TNIP1 act synergistically and partly redundantly to suppress TNF-induced epithelial cell death.","evidence":"IEC-specific A20/ABIN-1 double-knockout mice, enteroids, and RIPK1/RIPK3/caspase rescue experiments","pmids":["29930103"],"confidence":"High","gaps":["Whether synergy reflects shared complex assembly not biochemically dissected"]},{"year":2013,"claim":"Placed TNIP1 genetically upstream of MyD88 in dendritic-cell TLR signaling, connecting its loss to IL-23 production and psoriasiform disease.","evidence":"CD11c-Cre conditional knockout with MyD88 epistasis and cytokine/flow analyses","pmids":["23785118"],"confidence":"High","gaps":["Direct molecular target within MyD88 pathway not identified"]},{"year":2016,"claim":"Established keratinocytes as a cell-autonomous site of TNIP1 action restraining IL-17 signaling in psoriasis.","evidence":"Tissue-specific conditional knockout with in vitro IL-17 stimulation and in vivo inflammatory triggers","pmids":["27671649"],"confidence":"High","gaps":["Molecular link between TNIP1 and IL-17 receptor signaling not mapped"]},{"year":2009,"claim":"Identified TNIP1 as an atypical RAR corepressor that binds liganded receptors via NR-box/LXXLL motifs yet competes with coactivators.","evidence":"Two-hybrid, Co-IP, RAR reporter assays, and domain mapping with SRC1 competition","pmids":["19732752"],"confidence":"Medium","gaps":["Mechanism of repression at target promoters not defined"]},{"year":2011,"claim":"Generalized the corepressor role to agonist-bound PPARs and defined feedback wiring whereby NF-κB, PPARγ, and RARs transcriptionally control TNIP1.","evidence":"cDNA library two-hybrid, reporter assays, EMSA/ChIP of NF-κB/PPRE/RARE promoter elements, and skin localization studies","pmids":["21967852","22001530","22147607","23228856"],"confidence":"Medium","gaps":["Physiological weight of corepressor vs cytoplasmic signaling roles unresolved","Endogenous occupancy in vivo not established"]},{"year":2018,"claim":"Showed dose-sensitive and infection-context regulation of TNIP1, including antiviral pattern-recognition-receptor induction and pathogen-driven destabilization.","evidence":"Abin-1+/- mice with RIPK1 inhibitor, and NLRP10 Co-IP/stability assays during Shigella infection","pmids":["30341420","30510071"],"confidence":"Medium","gaps":["Direct vs indirect control of TLR3/RIG-I/MDA5 expression unresolved","NLRP10-TNIP1 axis tested in single cell system"]},{"year":2017,"claim":"Demonstrated post-translational and transcriptional counter-regulation of TNIP1 by IL-17, with A20-independent restraint of NF-κB.","evidence":"Protein stability/proteasome-inhibitor assays, NF-κB reporters, and A20 knockdown in fibroblasts","pmids":["30761389"],"confidence":"Medium","gaps":["E3 ligase driving IL-17-induced degradation not identified"]},{"year":2022,"claim":"Defined a non-canonical role for TNIP1 in T-cell CBM signaling, where its suppressive function requires A20 and it antagonizes MALT1 cleavage of A20.","evidence":"Quantitative MS interactome, NF-κB and MALT1 protease assays, and overexpression/knockdown in activated T cells","pmids":["35099607"],"confidence":"Medium","gaps":["Direct CBM-binding interface of TNIP1 not mapped"]},{"year":2022,"claim":"Connected inflammatory signaling to autophagic turnover of TNIP1: TBK1 phosphorylation activates its LIR motif to drive selective autophagic degradation that licenses inflammatory initiation.","evidence":"Phosphoproteomics, TBK1 inhibition, LIR mutagenesis, and autophagy-flux assays under TLR3 stimulation","pmids":["36574265"],"confidence":"High","gaps":["Receptor delivering TNIP1 to autophagosomes not fully defined here"]},{"year":2022,"claim":"Established direct LC3 binding and a positive role for TNIP1 in clearing damaged mitochondria.","evidence":"Bacterial direct-binding assays, LIR mutagenesis, CRISPR knockout, and mitophagy flux reporters tracking VDAC-1/MFN2/TOM20","pmids":["36440857"],"confidence":"High","gaps":["Apparent positive role contrasts with later negative-regulator model; context dependence not reconciled"]},{"year":2023,"claim":"Resolved TNIP1 as a negative regulator of mitophagy via bipartite LC3/GABARAP (LIR) and TAX1BP1 (AHD3) binding plus phosphorylation-controlled FIP200 association, letting it compete with autophagy receptors at autophagosome biogenesis.","evidence":"TNIP1-KO HeLa cells, domain mutagenesis, Co-IP with LC3/GABARAP/TAX1BP1/FIP200, and mitophagy flux assays","pmids":["36898370"],"confidence":"High","gaps":["Kinase governing the FIP200-regulating phosphorylation not identified here","Reconciliation with positive mitophagy role unresolved"]},{"year":2023,"claim":"Identified m6A-dependent control of TNIP1: FTO demethylation represses TNIP1, derepressing NF-κB in endothelium with in vivo disease relevance.","evidence":"MeRIP-seq, RNA pull-down, luciferase assays, FTO knockdown, and AAV-Tnip1 rescue of diabetic retinal damage","pmids":["37781923"],"confidence":"High","gaps":["m6A reader linking demethylation to TNIP1 stability/translation not defined"]},{"year":2024,"claim":"Linked a TNIP1 coding variant mechanistically to autoimmunity by showing Q333P impairs mitochondrial recruitment and MyD88/IRAK1 autophagosomal delivery, amplifying TLR7-driven disease.","evidence":"Whole-exome sequencing, knock-in mouse, cell-autonomous B-cell transfer, and TLR7/MyD88 epistasis with subcellular imaging","pmids":["39060650"],"confidence":"High","gaps":["Structural basis by which Q333P disrupts membrane/receptor recruitment not solved"]},{"year":null,"claim":"How TNIP1's distinct activities — NF-κB inhibition, death restraint, nuclear-receptor corepression, and autophagy regulation — are coordinated within a single cell, and how the positive vs negative mitophagy roles are reconciled, remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No integrated structural model of multidomain function","Context-dependence of mitophagy regulation unresolved","Quantitative balance between cytoplasmic and nuclear pools unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,3]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,3]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,10]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[14,15]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,4]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[16]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[16]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[20,23]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,7,23]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2,3,8]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[9,10,20]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[14,15,17]}],"complexes":["TNF receptor signaling complex (TNF-RSC)","CBM (CARD11-BCL10-MALT1) signalosome","A20 ubiquitin-editing complex"],"partners":["TNFAIP3","IKBKG","RIPK1","MAP1LC3B","TAX1BP1","RB1CC1","RARA","PPARA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15025","full_name":"TNFAIP3-interacting protein 1","aliases":["A20-binding inhibitor of NF-kappa-B activation 1","ABIN-1","HIV-1 Nef-interacting protein","Nef-associated factor 1","Naf1","Nip40-1","Virion-associated nuclear shuttling protein","VAN","hVAN"],"length_aa":636,"mass_kda":71.9,"function":"Inhibits NF-kappa-B activation and TNF-induced NF-kappa-B-dependent gene expression by regulating TAX1BP1 and A20/TNFAIP3-mediated deubiquitination of IKBKG; proposed to link A20/TNFAIP3 to ubiquitinated IKBKG (PubMed:21885437). Involved in regulation of EGF-induced ERK1/ERK2 signaling pathway; blocks MAPK3/MAPK1 nuclear translocation and MAPK1-dependent transcription. Increases cell surface CD4(T4) antigen expression. Involved in the anti-inflammatory response of macrophages and positively regulates TLR-induced activation of CEBPB. Involved in the prevention of autoimmunity; this function implicates binding to polyubiquitin. Involved in leukocyte integrin activation during inflammation; this function is mediated by association with SELPLG and dependent on phosphorylation by SRC-family kinases. Interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. May regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production. In case of infection, promotes association of IKBKG with Shigella flexneri E3 ubiquitin-protein ligase ipah9.8 p which in turn promotes polyubiquitination of IKBKG leading to its proteasome-dependent degradation and thus is perturbing NF-kappa-B activation during bacterial infection","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q15025/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TNIP1","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":true,"resolved_as":"NAF1","ensg_id":"ENSG00000145414","cell_line_id":"CID001114","localizations":[{"compartment":"nucleoplasm","grade":3},{"compartment":"chromatin","grade":2},{"compartment":"nucleolus_fc_dfc","grade":2},{"compartment":"nuclear_punctae","grade":1}],"interactors":[{"gene":"DKC1","stoichiometry":10.0},{"gene":"NOP10","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001114","total_profiled":1310},"omim":[{"mim_id":"612599","title":"PSORIASIS 11, SUSCEPTIBILITY TO; PSORS11","url":"https://www.omim.org/entry/612599"},{"mim_id":"612378","title":"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13","url":"https://www.omim.org/entry/612378"},{"mim_id":"612253","title":"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11","url":"https://www.omim.org/entry/612253"},{"mim_id":"612251","title":"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10; SLEB10","url":"https://www.omim.org/entry/612251"},{"mim_id":"609939","title":"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6","url":"https://www.omim.org/entry/609939"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TNIP1"},"hgnc":{"alias_symbol":["NAF1","KIAA0113","ABIN-1","VAN"],"prev_symbol":[]},"alphafold":{"accession":"Q15025","domains":[{"cath_id":"1.20.5","chopping":"24-71","consensus_level":"medium","plddt":90.7271,"start":24,"end":71}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15025","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15025-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15025-F1-predicted_aligned_error_v6.png","plddt_mean":70.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TNIP1","jax_strain_url":"https://www.jax.org/strain/search?query=TNIP1"},"sequence":{"accession":"Q15025","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15025.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15025/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15025"}},"corpus_meta":[{"pmid":"12219090","id":"PMC_12219090","title":"Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12219090","citation_count":657,"is_preprint":false},{"pmid":"9725839","id":"PMC_9725839","title":"Van Gogh: a new Drosophila tissue polarity gene.","date":"1998","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9725839","citation_count":263,"is_preprint":false},{"pmid":"32188941","id":"PMC_32188941","title":"General synthesis of two-dimensional van der Waals heterostructure arrays.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32188941","citation_count":239,"is_preprint":false},{"pmid":"10700184","id":"PMC_10700184","title":"Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10700184","citation_count":231,"is_preprint":false},{"pmid":"16684768","id":"PMC_16684768","title":"ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16684768","citation_count":222,"is_preprint":false},{"pmid":"21750679","id":"PMC_21750679","title":"Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21750679","citation_count":187,"is_preprint":false},{"pmid":"17547743","id":"PMC_17547743","title":"Ellis-van Creveld syndrome.","date":"2007","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17547743","citation_count":146,"is_preprint":false},{"pmid":"19060883","id":"PMC_19060883","title":"ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development.","date":"2008","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19060883","citation_count":142,"is_preprint":false},{"pmid":"33597507","id":"PMC_33597507","title":"Van der Waals engineering of ferroelectric heterostructures for long-retention memory.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33597507","citation_count":116,"is_preprint":false},{"pmid":"24805055","id":"PMC_24805055","title":"Many-body van der Waals interactions in molecules and condensed matter.","date":"2014","source":"Journal of physics. Condensed matter : an Institute of Physics journal","url":"https://pubmed.ncbi.nlm.nih.gov/24805055","citation_count":108,"is_preprint":false},{"pmid":"9463328","id":"PMC_9463328","title":"Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21.","date":"1998","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9463328","citation_count":105,"is_preprint":false},{"pmid":"12586352","id":"PMC_12586352","title":"Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12586352","citation_count":102,"is_preprint":false},{"pmid":"25885484","id":"PMC_25885484","title":"ProteinVolume: calculating molecular van der Waals and void volumes in proteins.","date":"2015","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/25885484","citation_count":102,"is_preprint":false},{"pmid":"10330353","id":"PMC_10330353","title":"Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21.","date":"1999","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10330353","citation_count":97,"is_preprint":false},{"pmid":"23074140","id":"PMC_23074140","title":"Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers.","date":"2013","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/23074140","citation_count":94,"is_preprint":false},{"pmid":"29203883","id":"PMC_29203883","title":"ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC.","date":"2017","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/29203883","citation_count":91,"is_preprint":false},{"pmid":"15475117","id":"PMC_15475117","title":"Van Gogh-like2 (Strabismus) and its role in planar cell polarity and convergent extension in vertebrates.","date":"2004","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/15475117","citation_count":88,"is_preprint":false},{"pmid":"31320651","id":"PMC_31320651","title":"Self-selective van der Waals heterostructures for large scale memory array.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31320651","citation_count":88,"is_preprint":false},{"pmid":"28931804","id":"PMC_28931804","title":"Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28931804","citation_count":76,"is_preprint":false},{"pmid":"20849588","id":"PMC_20849588","title":"Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study.","date":"2010","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/20849588","citation_count":71,"is_preprint":false},{"pmid":"27671649","id":"PMC_27671649","title":"Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27671649","citation_count":71,"is_preprint":false},{"pmid":"37781923","id":"PMC_37781923","title":"FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1.","date":"2023","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/37781923","citation_count":67,"is_preprint":false},{"pmid":"22833143","id":"PMC_22833143","title":"Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/22833143","citation_count":64,"is_preprint":false},{"pmid":"22542476","id":"PMC_22542476","title":"Emerging roles for TNIP1 in regulating post-receptor signaling.","date":"2012","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/22542476","citation_count":59,"is_preprint":false},{"pmid":"29080811","id":"PMC_29080811","title":"Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.","date":"2017","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/29080811","citation_count":59,"is_preprint":false},{"pmid":"23220543","id":"PMC_23220543","title":"Novel and recurrent EVC and EVC2 mutations in Ellis-van Creveld syndrome and Weyers acrofacial dyostosis.","date":"2012","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23220543","citation_count":59,"is_preprint":false},{"pmid":"30402506","id":"PMC_30402506","title":"TNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling.","date":"2018","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/30402506","citation_count":58,"is_preprint":false},{"pmid":"31414085","id":"PMC_31414085","title":"Optoelectronic and solar cell applications of Janus monolayers and their van der Waals heterostructures.","date":"2019","source":"Physical chemistry chemical physics : PCCP","url":"https://pubmed.ncbi.nlm.nih.gov/31414085","citation_count":57,"is_preprint":false},{"pmid":"22896740","id":"PMC_22896740","title":"Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.","date":"2012","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22896740","citation_count":53,"is_preprint":false},{"pmid":"29930103","id":"PMC_29930103","title":"A20 and ABIN-1 synergistically preserve intestinal epithelial cell survival.","date":"2018","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29930103","citation_count":52,"is_preprint":false},{"pmid":"839528","id":"PMC_839528","title":"Van der Waals interactions between cell surfaces.","date":"1977","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/839528","citation_count":46,"is_preprint":false},{"pmid":"23785118","id":"PMC_23785118","title":"Cutting edge: ABIN-1 protects against psoriasis by restricting MyD88 signals in dendritic cells.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23785118","citation_count":45,"is_preprint":false},{"pmid":"31452100","id":"PMC_31452100","title":"Van der Waals Potential in Protein Complexes.","date":"2019","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/31452100","citation_count":45,"is_preprint":false},{"pmid":"22087647","id":"PMC_22087647","title":"Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population.","date":"2011","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22087647","citation_count":45,"is_preprint":false},{"pmid":"28973407","id":"PMC_28973407","title":"GLI1 inactivation is associated with developmental phenotypes overlapping with Ellis-van Creveld syndrome.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28973407","citation_count":44,"is_preprint":false},{"pmid":"12965196","id":"PMC_12965196","title":"Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarrays.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12965196","citation_count":43,"is_preprint":false},{"pmid":"32758449","id":"PMC_32758449","title":"Episignatures Stratifying Helsmoortel-Van Der Aa Syndrome Show Modest Correlation with Phenotype.","date":"2020","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32758449","citation_count":42,"is_preprint":false},{"pmid":"16025521","id":"PMC_16025521","title":"Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality.","date":"2005","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/16025521","citation_count":40,"is_preprint":false},{"pmid":"15053985","id":"PMC_15053985","title":"Identification and developmental expression pattern of van gogh-like 1, a second zebrafish strabismus homologue.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15053985","citation_count":36,"is_preprint":false},{"pmid":"15722346","id":"PMC_15722346","title":"Adenoviral gene transfer of the NF-kappa B inhibitory protein ABIN-1 decreases allergic airway inflammation in a murine asthma model.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15722346","citation_count":35,"is_preprint":false},{"pmid":"3491128","id":"PMC_3491128","title":"Genetic epidemiology and control of genetic expression in van der Woude syndrome.","date":"1986","source":"Journal of craniofacial genetics and developmental biology. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/3491128","citation_count":34,"is_preprint":false},{"pmid":"36958333","id":"PMC_36958333","title":"Genomic analyses of hair from Ludwig van Beethoven.","date":"2023","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/36958333","citation_count":33,"is_preprint":false},{"pmid":"19251731","id":"PMC_19251731","title":"Analysis of Ellis van Creveld syndrome gene products: implications for cardiovascular development and disease.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19251731","citation_count":33,"is_preprint":false},{"pmid":"24091983","id":"PMC_24091983","title":"Variants in TNFSF4, TNFAIP3, TNIP1, BLK, SLC15A4 and UBE2L3 interact to confer risk of systemic lupus erythematosus in Chinese population.","date":"2013","source":"Rheumatology international","url":"https://pubmed.ncbi.nlm.nih.gov/24091983","citation_count":32,"is_preprint":false},{"pmid":"36898370","id":"PMC_36898370","title":"TNIP1 inhibits selective autophagy via bipartite interaction with LC3/GABARAP and TAX1BP1.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/36898370","citation_count":31,"is_preprint":false},{"pmid":"29512895","id":"PMC_29512895","title":"The Dynamics of Chemical Reactions: Atomistic Visualizations of Organic Reactions, and Homage to van 't Hoff.","date":"2018","source":"Chemistry (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/29512895","citation_count":31,"is_preprint":false},{"pmid":"12920575","id":"PMC_12920575","title":"Novel mutations in the IRF6 gene for Van der Woude syndrome.","date":"2003","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12920575","citation_count":30,"is_preprint":false},{"pmid":"19695220","id":"PMC_19695220","title":"ABIN-1 negatively regulates NF-kappaB by inhibiting processing of the p105 precursor.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19695220","citation_count":29,"is_preprint":false},{"pmid":"31691497","id":"PMC_31691497","title":"TNIP1-mediated TNF-α/NF-κB signalling cascade sustains glioma cell proliferation.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31691497","citation_count":28,"is_preprint":false},{"pmid":"26046540","id":"PMC_26046540","title":"Downregulation of TNIP1 Expression Leads to Increased Proliferation of Human Keratinocytes and Severer Psoriasis-Like Conditions in an Imiquimod-Induced Mouse Model of Dermatitis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26046540","citation_count":28,"is_preprint":false},{"pmid":"22147607","id":"PMC_22147607","title":"TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations.","date":"2011","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/22147607","citation_count":28,"is_preprint":false},{"pmid":"30319618","id":"PMC_30319618","title":"TNIP1 Regulates Cutibacterium acnes-Induced Innate Immune Functions in Epidermal Keratinocytes.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30319618","citation_count":27,"is_preprint":false},{"pmid":"29961509","id":"PMC_29961509","title":"Genetic, Radiologic, and Clinical Variability in Brown-Vialetto-van Laere Syndrome.","date":"2017","source":"Seminars in pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29961509","citation_count":27,"is_preprint":false},{"pmid":"30341420","id":"PMC_30341420","title":"ABIN-1 heterozygosity sensitizes to innate immune response in both RIPK1-dependent and RIPK1-independent manner.","date":"2018","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/30341420","citation_count":26,"is_preprint":false},{"pmid":"36574265","id":"PMC_36574265","title":"TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.","date":"2022","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36574265","citation_count":26,"is_preprint":false},{"pmid":"23541940","id":"PMC_23541940","title":"TNIP1/ANXA6 and CSMD1 variants interacting with cigarette smoking, alcohol intake affect risk of psoriasis.","date":"2013","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/23541940","citation_count":26,"is_preprint":false},{"pmid":"37126957","id":"PMC_37126957","title":"Amelioration of ovalbumin gel properties by EGCG via protein aggregation, hydrogen, and van der Waals force.","date":"2023","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37126957","citation_count":26,"is_preprint":false},{"pmid":"35042540","id":"PMC_35042540","title":"Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1.","date":"2022","source":"Genome medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35042540","citation_count":25,"is_preprint":false},{"pmid":"38233431","id":"PMC_38233431","title":"Broadband miniaturized spectrometers with a van der Waals tunnel diode.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38233431","citation_count":25,"is_preprint":false},{"pmid":"35099607","id":"PMC_35099607","title":"A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/35099607","citation_count":24,"is_preprint":false},{"pmid":"33542218","id":"PMC_33542218","title":"ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33542218","citation_count":24,"is_preprint":false},{"pmid":"30761389","id":"PMC_30761389","title":"Interleukin-17 signaling triggers degradation of the constitutive NF-κB inhibitor ABIN-1.","date":"2017","source":"ImmunoHorizons","url":"https://pubmed.ncbi.nlm.nih.gov/30761389","citation_count":24,"is_preprint":false},{"pmid":"19732752","id":"PMC_19732752","title":"Liganded RARalpha and RARgamma interact with but are repressed by TNIP1.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19732752","citation_count":23,"is_preprint":false},{"pmid":"15013698","id":"PMC_15013698","title":"A novel mutation of the IRF6 gene in an Italian family with Van der Woude syndrome.","date":"2004","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/15013698","citation_count":21,"is_preprint":false},{"pmid":"23949966","id":"PMC_23949966","title":"Search for genetic modifiers of IRF6 and genotype-phenotype correlations in Van der Woude and popliteal pterygium syndromes.","date":"2013","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/23949966","citation_count":21,"is_preprint":false},{"pmid":"34526632","id":"PMC_34526632","title":"Microbial community of soda Lake Van as obtained from direct and enriched water, sediment and fish samples.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34526632","citation_count":21,"is_preprint":false},{"pmid":"21967852","id":"PMC_21967852","title":"TNIP1 is a corepressor of agonist-bound PPARs.","date":"2011","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/21967852","citation_count":20,"is_preprint":false},{"pmid":"22001530","id":"PMC_22001530","title":"PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22001530","citation_count":20,"is_preprint":false},{"pmid":"14615938","id":"PMC_14615938","title":"A common mutation and a novel mutation in Japanese patients with van der Knaap disease.","date":"2003","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14615938","citation_count":20,"is_preprint":false},{"pmid":"28473721","id":"PMC_28473721","title":"Low-basicity 5-HT7 Receptor Agonists Synthesized Using the van Leusen Multicomponent Protocol.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28473721","citation_count":20,"is_preprint":false},{"pmid":"19016715","id":"PMC_19016715","title":"Van-den Berghe's 5q- syndrome in 2008.","date":"2008","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/19016715","citation_count":19,"is_preprint":false},{"pmid":"22766032","id":"PMC_22766032","title":"Association of UBQLN1 mutation with Brown-Vialetto-Van Laere syndrome but not typical ALS.","date":"2012","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/22766032","citation_count":19,"is_preprint":false},{"pmid":"30510071","id":"PMC_30510071","title":"NLRP10 Affects the Stability of Abin-1 To Control Inflammatory Responses.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30510071","citation_count":18,"is_preprint":false},{"pmid":"28915643","id":"PMC_28915643","title":"Relationship between the TERT, TNIP1 and OBFC1 genetic polymorphisms and susceptibility to colorectal cancer in Chinese Han population.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28915643","citation_count":18,"is_preprint":false},{"pmid":"23858047","id":"PMC_23858047","title":"Single-nucleotide polymorphism and haplotypes of TNIP1 associated with systemic lupus erythematosus in a Chinese Han population.","date":"2013","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/23858047","citation_count":17,"is_preprint":false},{"pmid":"33122334","id":"PMC_33122334","title":"TNIP1/ABIN1 and lupus nephritis: review.","date":"2020","source":"Lupus science & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33122334","citation_count":16,"is_preprint":false},{"pmid":"23579212","id":"PMC_23579212","title":"Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.","date":"2013","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23579212","citation_count":16,"is_preprint":false},{"pmid":"25264125","id":"PMC_25264125","title":"Investigating the genetic association of HCP5, SPATA2, TNIP1, TNFAIP3 and COG6 with psoriasis in Chinese population.","date":"2014","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/25264125","citation_count":16,"is_preprint":false},{"pmid":"39856414","id":"PMC_39856414","title":"Interlayer reconstruction phase transition in van der Waals materials.","date":"2025","source":"Nature materials","url":"https://pubmed.ncbi.nlm.nih.gov/39856414","citation_count":16,"is_preprint":false},{"pmid":"23756825","id":"PMC_23756825","title":"Analysis of germ cell proliferation, apoptosis, and androgenesis in the Lake Van fish (Chalcalburnus tarichi) during testicular development.","date":"2013","source":"Fish physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23756825","citation_count":16,"is_preprint":false},{"pmid":"29413846","id":"PMC_29413846","title":"TNIP1 reduction sensitizes keratinocytes to post-receptor signalling following exposure to TLR agonists.","date":"2018","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/29413846","citation_count":15,"is_preprint":false},{"pmid":"26738398","id":"PMC_26738398","title":"TNFAIP3 and TNIP1 polymorphisms confer psoriasis risk in South Indian Tamils.","date":"2015","source":"British journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/26738398","citation_count":15,"is_preprint":false},{"pmid":"25675977","id":"PMC_25675977","title":"Clinical manifestations and laboratory findings of 496 children with brucellosis in Van, Turkey.","date":"2015","source":"Pediatrics international : official journal of the Japan Pediatric Society","url":"https://pubmed.ncbi.nlm.nih.gov/25675977","citation_count":15,"is_preprint":false},{"pmid":"39060650","id":"PMC_39060650","title":"A TNIP1-driven systemic autoimmune disorder with elevated IgG4.","date":"2024","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39060650","citation_count":13,"is_preprint":false},{"pmid":"29709475","id":"PMC_29709475","title":"TNIP1 alleviates hepatic ischemia/reperfusion injury via the TLR2-Myd88 pathway.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29709475","citation_count":13,"is_preprint":false},{"pmid":"17016622","id":"PMC_17016622","title":"Multiple splicing variants of Naf1/ABIN-1 transcripts and their alterations in hematopoietic tumors.","date":"2006","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17016622","citation_count":13,"is_preprint":false},{"pmid":"33325104","id":"PMC_33325104","title":"Brown-Vialetto-Van Laere and Fazio-Londe syndromes: SLC52A3 mutations with puzzling phenotypes and inheritance.","date":"2021","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33325104","citation_count":13,"is_preprint":false},{"pmid":"18506368","id":"PMC_18506368","title":"Identification of IRF6 gene variants in three families with Van der Woude syndrome.","date":"2008","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18506368","citation_count":13,"is_preprint":false},{"pmid":"17122170","id":"PMC_17122170","title":"A novel missense mutation in Van der Woude syndrome: usefulness of fingernail DNA for genetic analysis.","date":"2006","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/17122170","citation_count":13,"is_preprint":false},{"pmid":"27129285","id":"PMC_27129285","title":"Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1.","date":"2016","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/27129285","citation_count":12,"is_preprint":false},{"pmid":"26748586","id":"PMC_26748586","title":"Truncation and microdeletion of EVC/EVC2 with missense mutation of EFCAB7 in Ellis-van Creveld syndrome.","date":"2016","source":"Congenital anomalies","url":"https://pubmed.ncbi.nlm.nih.gov/26748586","citation_count":12,"is_preprint":false},{"pmid":"24443180","id":"PMC_24443180","title":"Transposon-dependent induction of Vincent van Gogh's sunflowers: exceptions revealed.","date":"2014","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/24443180","citation_count":12,"is_preprint":false},{"pmid":"29589214","id":"PMC_29589214","title":"Association of Tumor Necrosis Factor Alpha-Induced Protein 3 Interacting Protein 1 (TNIP1) Gene Polymorphism (rs7708392) with Lupus Nephritis in Egyptian Patients.","date":"2018","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29589214","citation_count":11,"is_preprint":false},{"pmid":"36440857","id":"PMC_36440857","title":"A20 binding and inhibitor of nuclear factor kappa B (NF-κB)-1 (ABIN-1): a novel modulator of mitochondrial autophagy.","date":"2022","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/36440857","citation_count":10,"is_preprint":false},{"pmid":"23228856","id":"PMC_23228856","title":"Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptors.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23228856","citation_count":10,"is_preprint":false},{"pmid":"26077781","id":"PMC_26077781","title":"Ellis-van Creveld Syndrome in Grey Alpine Cattle: Morphologic, Immunophenotypic, and Molecular Characterization.","date":"2015","source":"Veterinary pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26077781","citation_count":10,"is_preprint":false},{"pmid":"21468557","id":"PMC_21468557","title":"Novel IRF6 mutations in Honduran Van der Woude syndrome patients.","date":"2011","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21468557","citation_count":10,"is_preprint":false},{"pmid":"8882877","id":"PMC_8882877","title":"Exclusion of the MSX1 homeobox gene as the gene for the Ellis van Creveld syndrome in the Amish.","date":"1996","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8882877","citation_count":10,"is_preprint":false},{"pmid":"29237725","id":"PMC_29237725","title":"ABIN-1 Negatively Regulates μ-Opioid Receptor Function.","date":"2017","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29237725","citation_count":9,"is_preprint":false},{"pmid":"32100889","id":"PMC_32100889","title":"ABIN-1 protects chondrocytes from lipopolysaccharide-induced inflammatory injury through the inactivation of NF-κB signalling.","date":"2020","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32100889","citation_count":9,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50151,"output_tokens":6652,"usd":0.125116,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15724,"output_tokens":5832,"usd":0.11221,"stage2_stop_reason":"end_turn"},"total_usd":0.237326,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"ABIN-1 (TNIP1) physically binds NEMO/IKKγ and facilitates A20-mediated de-ubiquitination of NEMO/IKKγ, thereby inhibiting NF-κB activation. ABIN-1 links A20 to NEMO/IKKγ; siRNA targeting ABIN-1 abrogates A20-dependent de-ubiquitination of NEMO/IKKγ.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, NF-κB reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and functional siRNA experiments in single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16684768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ABIN-1 contains an ABIN homology domain (AHD) shared with IKKγ/NEMO; site-specific mutagenesis of this AHD2 region abolishes NF-κB inhibitory function without affecting A20 interaction, indicating A20 binding and NF-κB inhibition are separable activities. Dominant-negative AHD2 mutants interfere with ABIN-1 but not A20-mediated NF-κB inhibition.\",\n      \"method\": \"Site-directed mutagenesis, NF-κB reporter assays, co-immunoprecipitation\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — mutagenesis with functional validation plus protein interaction assays in single lab\",\n      \"pmids\": [\"12586352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ABIN-1 directly binds polyubiquitin chains (ubiquitin-sensing activity), and this activity is required for its anti-apoptotic function. ABIN-1-deficient mice die embryonically with fetal liver apoptosis rescued by TNF deficiency; ABIN-1 inhibits caspase-8 recruitment to FADD in TNF-induced signaling complexes, preventing caspase-8 cleavage and programmed cell death.\",\n      \"method\": \"Knockout mouse model, genetic rescue (TNF deficiency), biochemical ubiquitin-binding assays, signaling complex analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo knockout with genetic epistasis, direct biochemical ubiquitin-binding assay, and mechanistic complex analysis in single rigorous study\",\n      \"pmids\": [\"19060883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ABIN-1 is recruited to the TNF-RSC in a LUBAC-dependent (Met1-ubiquitin-dependent) manner and regulates A20 recruitment to control Lys63 deubiquitylation of RIPK1. ABIN-1 deficiency reduces A20 recruitment, promotes Lys63 ubiquitylation and activation of RIPK1, and licenses necroptosis. RIPK1 kinase inhibition and RIPK3 deficiency rescue embryonic lethality of Abin-1−/− mice.\",\n      \"method\": \"Knockout mouse model, genetic rescue experiments, biochemical analysis of TNF-RSC complex, ubiquitylation assays, RIPK1 kinase inhibitor treatment\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods including in vivo genetic rescue, complex biochemistry, and pharmacological inhibition in one rigorous study\",\n      \"pmids\": [\"29203883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ABIN-1 inhibits NF-κB by blocking processing of the p105 precursor to the p50 active subunit. ABIN-1 physically interacts with p105, and this interaction stabilizes ABIN-1 and increases its inhibitory effect. The AHD2 domain of ABIN-1 is required for inhibition of p105 processing.\",\n      \"method\": \"Co-immunoprecipitation, NF-κB reporter assays, domain deletion analysis, Western blotting\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP with domain mapping and functional assays in single lab\",\n      \"pmids\": [\"19695220\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Adenoviral ABIN-1 expression protects mice from TNF/galactosamine-induced acute liver failure; ABIN-1 prevents both TNF-induced NF-κB activation and hepatocyte apoptosis, demonstrating an NF-κB-independent anti-apoptotic activity distinct from IκBα superrepressor.\",\n      \"method\": \"Adenoviral gene transfer in murine liver failure model, comparison with IκBα superrepressor, histological analysis of apoptosis and inflammation\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gene transfer with mechanistic comparison to IκBα, single lab\",\n      \"pmids\": [\"16025521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ABIN-1 deficiency specifically in dendritic cells leads to exaggerated NF-κB and MAPK signaling and increased IL-23 production in response to TLR ligands. DC-specific ABIN-1 deletion causes psoriasiform lesions upon TLR7 challenge, and these phenotypes are reversed by DC-specific deletion of the TLR adaptor MyD88, placing ABIN-1 upstream of MyD88 in DC TLR signaling.\",\n      \"method\": \"Conditional knockout mice (CD11c-Cre), MyD88 genetic epistasis, cytokine measurements, flow cytometry for Th17/TCRγδ T cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type specific conditional KO with genetic epistasis (MyD88 rescue) clearly placing ABIN-1 upstream of MyD88 in TLR signaling in DCs\",\n      \"pmids\": [\"23785118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Loss of Tnip1 in keratinocytes leads to deregulated IL-17-induced gene expression and exaggerated chemokine production in vitro and overt psoriasis-like inflammation in vivo; tissue-specific deletion established that keratinocytes are a cell-autonomous contributor to psoriasis pathogenesis through TNIP1.\",\n      \"method\": \"Tissue-specific conditional knockout mice, in vitro keratinocyte stimulation with IL-17, in vivo inflammatory triggers\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with defined molecular phenotype (IL-17 signaling) and in vitro/in vivo orthogonal confirmation\",\n      \"pmids\": [\"27671649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A20 and ABIN-1 synergistically restrict TNF-induced caspase-8 activation and RIPK1 kinase activity in intestinal epithelial cells. Simultaneous IEC-specific deletion of both A20 and ABIN-1 causes spontaneous cell death and mouse lethality; single deletion of either alone has negligible effect. Inhibition of RIPK1 kinase alone, or caspase inhibition plus RIPK3 deletion, rescues the double-deficient phenotype.\",\n      \"method\": \"Conditional double-knockout mice, enteroid culture, genetic rescue experiments (RIPK1 inhibitor, RIPK3 deletion, caspase inhibition), caspase-8 activation assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional double-KO with multiple genetic epistasis rescues, cell-autonomous enteroid confirmation, single rigorous study\",\n      \"pmids\": [\"29930103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TBK1 phosphorylates TNIP1 under inflammatory conditions (TLR3/poly(I:C) stimulation), activating its LIR motif and leading to selective autophagy-dependent degradation of TNIP1. This early (0–4 h) degradation allows efficient initiation of the inflammatory response, after which TNIP1 levels are restored by increased transcription to prevent sustained inflammation.\",\n      \"method\": \"Phosphoproteomics, TBK1 inhibitor treatment, autophagy flux assays, LIR motif mutagenesis, quantitative proteomics\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — identification of kinase (TBK1), phosphorylation-dependent LIR activation, and autophagy-dependent degradation with mutagenesis and multiple orthogonal methods\",\n      \"pmids\": [\"36574265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TNIP1 negatively regulates mitophagy via a bipartite interaction: an evolutionarily conserved LIR motif binds LC3/GABARAP family proteins, and an AHD3 domain binds autophagy receptor TAX1BP1. TNIP1 knockout accelerates mitophagy; phosphorylation of TNIP1 regulates its association with the ULK1 complex member FIP200, allowing TNIP1 to compete with autophagy receptors at early steps of autophagosome biogenesis.\",\n      \"method\": \"TNIP1 knockout HeLa cells, ectopic overexpression, LIR/AHD3 domain mutagenesis, Co-IP with LC3/GABARAP/TAX1BP1/FIP200, mitophagy flux assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — domain mutagenesis, protein interaction validation, KO and OE rescue experiments, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"36898370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ABIN-1 is recruited to the CBM (CARD11-BCL10-MALT1) signalosome in activated T cells; its suppressive function in T cells depends on A20. A20 suppresses CBM complex-triggered NF-κB and MALT1 protease activity independent of ABIN-1, but ABIN-1's suppressive function requires A20. A20/ABIN-1 is recruited via A20 ZnF4/7; proteasomal degradation of both releases the CBM from negative regulation. ABIN-1 also antagonizes MALT1-catalyzed cleavage of re-synthesized A20.\",\n      \"method\": \"Quantitative mass spectrometry interactome, T cell activation assays, NF-κB reporter, MALT1 protease assay, overexpression and knockdown experiments\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative MS-based interactome plus functional assays, single lab\",\n      \"pmids\": [\"35099607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ABIN-1 heterozygosity sensitizes cells to antiviral response by mediating NF-κB-dependent, RIPK1-independent upregulation of pattern recognition molecules TLR3, RIG-I, and MDA5. Prolonged poly(I:C) stimulation leads to A20-dependent reduction of ABIN-1 protein. RIPK1 kinase inhibition partially reduces pattern recognition molecule expression in Abin-1+/- but not WT mice.\",\n      \"method\": \"Heterozygous Abin-1+/- mouse model, in vivo cytokine measurements, MEF signaling studies, RIPK1 kinase inhibitor treatment\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo mouse model plus pharmacological inhibition, single lab\",\n      \"pmids\": [\"30341420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IL-17 signaling induces proteasome-dependent degradation of ABIN-1 protein, while simultaneously inducing ABIN-1 mRNA through NF-κB. ABIN-1 restricts both baseline and IL-17-induced NF-κB signaling independently of A20 in IL-17-responsive fibroblasts.\",\n      \"method\": \"Protein stability assays, proteasome inhibitor treatment, NF-κB reporter assays, siRNA knockdown of A20, promoter activity assays\",\n      \"journal\": \"ImmunoHorizons\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — proteasome inhibitor-based mechanism plus multiple cell-based assays, single lab\",\n      \"pmids\": [\"30761389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TNIP1 interacts with liganded RARα and RARγ via NR boxes (LXXLL motifs) in a ligand- and receptor AF-2 domain-dependent manner characteristic of coactivators, yet TNIP1 represses RAR transcriptional activity. Repression is partially relieved by SRC1 coactivator, suggesting TNIP1 competes with coactivators. RARα preference over RARγ maps to helices 5-9 of the RARα ligand-binding domain.\",\n      \"method\": \"Two-hybrid assays, co-immunoprecipitation, RAR transcriptional activity reporter assays, domain deletion mapping\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — multiple protein interaction and functional assays with domain mapping, single lab\",\n      \"pmids\": [\"19732752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TNIP1 is an atypical corepressor of agonist-bound PPARα (and other PPARs); identified from a PPARα screen of a human keratinocyte cDNA library. TNIP1-PPAR interaction requires ligand and the receptor AF-2 domain. TNIP1 has separable transcriptional activation and repression domains. TNIP1 partially decreases PPAR transcriptional activity.\",\n      \"method\": \"cDNA library two-hybrid screen, co-immunoprecipitation, PPAR transcriptional reporter assays, domain deletion analysis\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — library screen plus functional validation with domain analysis, single lab\",\n      \"pmids\": [\"21967852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TNIP1 localizes to both cytoplasm and nucleus in normal human skin keratinocytes, where it co-localizes with RARα. Nuclear and cytoplasmic distribution is also observed in malignant keratinocytes of squamous cell carcinomas, with varying levels in different tumor types.\",\n      \"method\": \"Immunohistochemistry, co-localization analysis in tissue sections and cultured cells\",\n      \"journal\": \"The journal of histochemistry and cytochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization with co-localization to known binding partner RARα, multiple tissue types but without direct functional consequence assay\",\n      \"pmids\": [\"22147607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PPARγ and NF-κB directly regulate the TNIP1 gene promoter; validated NF-κB binding sites in proximal and distal promoter regions and one PPRE in the distal region were confirmed by EMSA and ChIP assays, establishing a feedback loop where NF-κB and PPARγ control their own inhibitor.\",\n      \"method\": \"Luciferase reporter assays, EMSA, chromatin immunoprecipitation (ChIP), expression studies\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP and EMSA with functional reporter validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"22001530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TNIP1 promoter is activated by retinoic acid (ATRA) via RAR-responsive elements (RAREs) in proximal and distal promoter regions, confirmed by EMSA, ChIP, and luciferase assays. This establishes a feedback loop: RARs activate TNIP1 expression, and TNIP1 in turn attenuates RAR activity.\",\n      \"method\": \"Luciferase reporter assays, EMSA, ChIP, expression studies with ATRA treatment\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP and EMSA with functional reporter confirmation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"23228856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NLRP10 binds ABIN-1 through its NACHT domain and destabilizes ABIN-1, resulting in enhanced proinflammatory NF-κB signaling during Shigella flexneri infection in human epithelial cells.\",\n      \"method\": \"Co-immunoprecipitation (NLRP10-ABIN-1), domain mapping, protein stability assays, NF-κB signaling readouts in infected cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP with domain mapping and functional signaling readout, single lab\",\n      \"pmids\": [\"30510071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ABIN-1 directly binds LC3A and LC3B via LIR motifs (LIR1 and LIR2); mutations in both LIR motifs abolish ABIN-1/LC3B-II complex formation. ABIN-1 translocates to damaged mitochondria and promotes mitophagy; CRISPR/Cas9 deletion of ABIN-1 inhibits degradation of outer mitochondrial membrane proteins VDAC-1, MFN2, and TOM20.\",\n      \"method\": \"Bacterial protein expression and direct binding assays, LIR motif mutagenesis, colocalization (fluorescence microscopy), CRISPR knockout, siRNA knockdown, mitophagy flux reporters\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct in vitro binding with mutagenesis, CRISPR KO phenotype, and live-cell mitophagy reporters; multiple orthogonal methods in single study\",\n      \"pmids\": [\"36440857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ABIN-1 physically associates with the μ-opioid receptor (MOR) C-terminal tail, confirmed by bacterial two-hybrid screen and co-immunoprecipitation. ABIN-1 inhibits DAMGO-induced G protein activation, MOR phosphorylation, ubiquitination, internalization, and ERK activation in CHO cells. ABIN-1 morpholino knockdown in zebrafish increases morphine-induced hyperlocomotion.\",\n      \"method\": \"Bacterial two-hybrid screen, co-immunoprecipitation, G protein activation assay (GTPγS), radioligand binding, adenylyl cyclase assay, zebrafish morpholino knockdown\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, multiple functional receptor assays, and in vivo zebrafish validation; single lab\",\n      \"pmids\": [\"29237725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FTO (m6A demethylase) erases m6A methylation on TNIP1 mRNA, repressing TNIP1 expression. FTO-mediated reduction of TNIP1 activates NF-κB and inflammatory factors in endothelial cells. Confirmed by MeRIP-seq, RNA-seq, luciferase activity assays, and RNA pull-down; intravitreal AAV-Tnip1 delivery alleviates diabetic retinal vascular damage.\",\n      \"method\": \"MeRIP-sequencing, RNA-seq, luciferase activity assays, RNA pull-down, FTO knockdown, AAV-mediated TNIP1 overexpression in vivo\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — MeRIP-seq identifies m6A site, RNA pull-down and luciferase confirm FTO-TNIP1 regulatory axis, in vivo rescue confirms functional consequence; multiple orthogonal methods\",\n      \"pmids\": [\"37781923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A TNIP1 Q333P variant impairs TNIP1 localization to damaged mitochondria and mitophagosome formation, and impairs MyD88 and IRAK1 recruitment to autophagosomes, resulting in increased interferon-β and TLR7-driven autoimmunity. B cell autoimmune phenotypes from this variant are cell-autonomous and rescued by ablation of TLR7 or MyD88.\",\n      \"method\": \"Whole-exome sequencing, knock-in mouse model (Q346P), cell-autonomous B cell transfer experiments, TLR7/MyD88 knockout epistasis, mitochondrial localization imaging, autophagosome recruitment assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — knock-in mouse with genetic epistasis (TLR7/MyD88 rescue), cell-autonomous transfer, and direct mechanistic subcellular localization studies in one rigorous study\",\n      \"pmids\": [\"39060650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LILRB1 ligation during monocyte-to-DC differentiation increases ABIN1/TNIP1 expression, mediating inhibitory effects on DC function. siRNA-mediated reduction of ABIN1/TNIP1 in these cells allows NF-κB nuclear translocation, increased surface antigen presentation molecules, phagocytic capacity, proinflammatory cytokine secretion, and T cell stimulation.\",\n      \"method\": \"siRNA knockdown of TNIP1 in DCs/monocytes, NF-κB translocation assay, flow cytometry for surface markers, phagocytosis assay, cytokine ELISA, T cell co-culture\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — siRNA KD with multiple downstream functional readouts, single lab\",\n      \"pmids\": [\"27129285\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TNIP1 (ABIN-1) is a multifunctional ubiquitin-sensing scaffold protein that inhibits NF-κB by binding polyubiquitin chains, linking A20 to NEMO/IKKγ for de-ubiquitylation, blocking p105 processing, and competing with autophagy receptors for FIP200/ULK1 complex access; it restricts TNF-induced apoptosis and necroptosis by preventing caspase-8/FADD complex assembly and RIPK1 Lys63-ubiquitylation/activation, acts as a corepressor of agonist-bound nuclear receptors (RARs, PPARs), undergoes TBK1-phosphorylation-dependent LIR-mediated autophagic degradation to permit inflammatory initiation, and is recruited to damaged mitochondria to promote mitophagy, with a disease-associated Q333P variant impairing mitophagosome formation and MyD88/IRAK1 autophagosomal recruitment, thereby amplifying TLR7-driven autoimmunity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TNIP1 (ABIN-1) is a ubiquitin-sensing scaffold protein that restrains inflammatory and cell-death signaling and, through a distinct set of domains, modulates selective autophagy [#2, #3, #10]. As an NF-\\u03baB inhibitor it binds polyubiquitin chains and uses an ABIN homology domain (AHD2) genetically separable from its A20-binding activity to block NF-\\u03baB; it links A20 to NEMO/IKK\\u03b3 to drive NEMO de-ubiquitination and additionally blocks processing of the p105 precursor to p50 [#0, #1, #4]. At the TNF receptor signaling complex it is recruited in a LUBAC/Met1-ubiquitin-dependent manner where it controls A20 recruitment and limits Lys63 ubiquitylation and activation of RIPK1, thereby preventing caspase-8/FADD-dependent apoptosis and licensing of necroptosis; loss of TNIP1 causes TNF-dependent embryonic lethality rescuable by TNF deficiency or RIPK1/RIPK3 inactivation [#2, #3, #8]. This cell-death-restraining role is partly synergistic with A20 in intestinal epithelium [#8]. In innate and adaptive immunity TNIP1 acts upstream of MyD88 in dendritic-cell TLR signaling and restrains IL-17-induced NF-\\u03baB programs in keratinocytes, with cell-type-specific loss producing psoriasis-like inflammation [#6, #7]. TNIP1 is itself a node of feedback control: its expression is induced by NF-\\u03baB, PPAR\\u03b3, and retinoic-acid receptors through defined promoter elements, and it acts as an atypical corepressor of agonist-bound RARs and PPARs via LXXLL/NR-box motifs [#14, #15, #17, #18]. Beyond signaling, TNIP1 uses a conserved LIR motif that binds LC3/GABARAP and an AHD3 domain that binds TAX1BP1, and its phosphorylation-regulated association with FIP200 lets it compete with autophagy receptors to negatively regulate mitophagy; TBK1-driven, LIR-dependent autophagic degradation of TNIP1 permits initiation of inflammation [#9, #10, #20]. A disease-associated Q333P variant impairs TNIP1 recruitment to damaged mitochondria and MyD88/IRAK1 autophagosomal recruitment, amplifying TLR7-driven autoimmunity [#23].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established that TNIP1's NF-\\u03baB-inhibitory activity is structurally and functionally separable from its A20 interaction, defining the AHD2 domain as the effector module.\",\n      \"evidence\": \"Site-directed mutagenesis of the AHD2 region with NF-\\u03baB reporter and Co-IP assays\",\n      \"pmids\": [\"12586352\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular target through which AHD2 blocks NF-\\u03baB not defined\", \"Single-lab functional mutagenesis\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed how TNIP1 inhibits NF-\\u03baB mechanistically: it bridges A20 to NEMO/IKK\\u03b3 to enable A20-dependent de-ubiquitination.\",\n      \"evidence\": \"Co-IP, siRNA knockdown, and NF-\\u03baB reporter assays\",\n      \"pmids\": [\"16684768\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry of the A20-TNIP1-NEMO complex not resolved\", \"In vivo relevance not tested here\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended the NF-\\u03baB-inhibitory repertoire by showing TNIP1 blocks p105-to-p50 processing through a p105 interaction requiring AHD2.\",\n      \"evidence\": \"Co-IP, domain deletion, and NF-\\u03baB reporter assays\",\n      \"pmids\": [\"19695220\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of processing inhibition unresolved\", \"Single-lab overexpression-based\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated an NF-\\u03baB-independent anti-apoptotic function in vivo distinct from IkBa, separating TNIP1's death-protective and transcriptional roles.\",\n      \"evidence\": \"Adenoviral TNIP1 transfer in a murine TNF/galactosamine liver-failure model with IkBa comparison\",\n      \"pmids\": [\"16025521\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of the anti-apoptotic activity not defined at this stage\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined TNIP1 as a polyubiquitin-binding protein essential for survival, linking ubiquitin sensing to suppression of caspase-8/FADD-driven apoptosis.\",\n      \"evidence\": \"Knockout mice with TNF-deficiency genetic rescue, biochemical ubiquitin-binding assays, and TNF signaling complex analysis\",\n      \"pmids\": [\"19060883\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ubiquitin chain-type specificity only partly defined\", \"Did not address necroptosis arm\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved how TNIP1 restrains necroptosis: LUBAC/Met1-ubiquitin-dependent recruitment to the TNF-RSC positions it to control A20 recruitment and RIPK1 Lys63-ubiquitylation/activation.\",\n      \"evidence\": \"Knockout mice, TNF-RSC biochemistry, ubiquitylation assays, and RIPK1-kinase-inhibitor/RIPK3-deficiency rescue of lethality\",\n      \"pmids\": [\"29203883\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Met1-ubiquitin binding by TNIP1 vs indirect recruitment not fully separated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed A20 and TNIP1 act synergistically and partly redundantly to suppress TNF-induced epithelial cell death.\",\n      \"evidence\": \"IEC-specific A20/ABIN-1 double-knockout mice, enteroids, and RIPK1/RIPK3/caspase rescue experiments\",\n      \"pmids\": [\"29930103\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether synergy reflects shared complex assembly not biochemically dissected\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placed TNIP1 genetically upstream of MyD88 in dendritic-cell TLR signaling, connecting its loss to IL-23 production and psoriasiform disease.\",\n      \"evidence\": \"CD11c-Cre conditional knockout with MyD88 epistasis and cytokine/flow analyses\",\n      \"pmids\": [\"23785118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target within MyD88 pathway not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established keratinocytes as a cell-autonomous site of TNIP1 action restraining IL-17 signaling in psoriasis.\",\n      \"evidence\": \"Tissue-specific conditional knockout with in vitro IL-17 stimulation and in vivo inflammatory triggers\",\n      \"pmids\": [\"27671649\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between TNIP1 and IL-17 receptor signaling not mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified TNIP1 as an atypical RAR corepressor that binds liganded receptors via NR-box/LXXLL motifs yet competes with coactivators.\",\n      \"evidence\": \"Two-hybrid, Co-IP, RAR reporter assays, and domain mapping with SRC1 competition\",\n      \"pmids\": [\"19732752\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of repression at target promoters not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Generalized the corepressor role to agonist-bound PPARs and defined feedback wiring whereby NF-\\u03baB, PPAR\\u03b3, and RARs transcriptionally control TNIP1.\",\n      \"evidence\": \"cDNA library two-hybrid, reporter assays, EMSA/ChIP of NF-\\u03baB/PPRE/RARE promoter elements, and skin localization studies\",\n      \"pmids\": [\"21967852\", \"22001530\", \"22147607\", \"23228856\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological weight of corepressor vs cytoplasmic signaling roles unresolved\", \"Endogenous occupancy in vivo not established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed dose-sensitive and infection-context regulation of TNIP1, including antiviral pattern-recognition-receptor induction and pathogen-driven destabilization.\",\n      \"evidence\": \"Abin-1+/- mice with RIPK1 inhibitor, and NLRP10 Co-IP/stability assays during Shigella infection\",\n      \"pmids\": [\"30341420\", \"30510071\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect control of TLR3/RIG-I/MDA5 expression unresolved\", \"NLRP10-TNIP1 axis tested in single cell system\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated post-translational and transcriptional counter-regulation of TNIP1 by IL-17, with A20-independent restraint of NF-\\u03baB.\",\n      \"evidence\": \"Protein stability/proteasome-inhibitor assays, NF-\\u03baB reporters, and A20 knockdown in fibroblasts\",\n      \"pmids\": [\"30761389\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase driving IL-17-induced degradation not identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined a non-canonical role for TNIP1 in T-cell CBM signaling, where its suppressive function requires A20 and it antagonizes MALT1 cleavage of A20.\",\n      \"evidence\": \"Quantitative MS interactome, NF-\\u03baB and MALT1 protease assays, and overexpression/knockdown in activated T cells\",\n      \"pmids\": [\"35099607\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CBM-binding interface of TNIP1 not mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connected inflammatory signaling to autophagic turnover of TNIP1: TBK1 phosphorylation activates its LIR motif to drive selective autophagic degradation that licenses inflammatory initiation.\",\n      \"evidence\": \"Phosphoproteomics, TBK1 inhibition, LIR mutagenesis, and autophagy-flux assays under TLR3 stimulation\",\n      \"pmids\": [\"36574265\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor delivering TNIP1 to autophagosomes not fully defined here\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established direct LC3 binding and a positive role for TNIP1 in clearing damaged mitochondria.\",\n      \"evidence\": \"Bacterial direct-binding assays, LIR mutagenesis, CRISPR knockout, and mitophagy flux reporters tracking VDAC-1/MFN2/TOM20\",\n      \"pmids\": [\"36440857\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Apparent positive role contrasts with later negative-regulator model; context dependence not reconciled\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Resolved TNIP1 as a negative regulator of mitophagy via bipartite LC3/GABARAP (LIR) and TAX1BP1 (AHD3) binding plus phosphorylation-controlled FIP200 association, letting it compete with autophagy receptors at autophagosome biogenesis.\",\n      \"evidence\": \"TNIP1-KO HeLa cells, domain mutagenesis, Co-IP with LC3/GABARAP/TAX1BP1/FIP200, and mitophagy flux assays\",\n      \"pmids\": [\"36898370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase governing the FIP200-regulating phosphorylation not identified here\", \"Reconciliation with positive mitophagy role unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified m6A-dependent control of TNIP1: FTO demethylation represses TNIP1, derepressing NF-\\u03baB in endothelium with in vivo disease relevance.\",\n      \"evidence\": \"MeRIP-seq, RNA pull-down, luciferase assays, FTO knockdown, and AAV-Tnip1 rescue of diabetic retinal damage\",\n      \"pmids\": [\"37781923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"m6A reader linking demethylation to TNIP1 stability/translation not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linked a TNIP1 coding variant mechanistically to autoimmunity by showing Q333P impairs mitochondrial recruitment and MyD88/IRAK1 autophagosomal delivery, amplifying TLR7-driven disease.\",\n      \"evidence\": \"Whole-exome sequencing, knock-in mouse, cell-autonomous B-cell transfer, and TLR7/MyD88 epistasis with subcellular imaging\",\n      \"pmids\": [\"39060650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis by which Q333P disrupts membrane/receptor recruitment not solved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TNIP1's distinct activities \\u2014 NF-\\u03baB inhibition, death restraint, nuclear-receptor corepression, and autophagy regulation \\u2014 are coordinated within a single cell, and how the positive vs negative mitophagy roles are reconciled, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No integrated structural model of multidomain function\", \"Context-dependence of mitophagy regulation unresolved\", \"Quantitative balance between cytoplasmic and nuclear pools unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 10]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [14, 15]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [20, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 7, 23]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 3, 8]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [9, 10, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [14, 15, 17]}\n    ],\n    \"complexes\": [\n      \"TNF receptor signaling complex (TNF-RSC)\",\n      \"CBM (CARD11-BCL10-MALT1) signalosome\",\n      \"A20 ubiquitin-editing complex\"\n    ],\n    \"partners\": [\n      \"TNFAIP3\",\n      \"IKBKG\",\n      \"RIPK1\",\n      \"MAP1LC3B\",\n      \"TAX1BP1\",\n      \"RB1CC1\",\n      \"RARA\",\n      \"PPARA\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}